Can a patient taking omeprazole (Proton Pump Inhibitor) also take Adderall XR (dextroamphetamine and amphetamine)

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Concomitant Use of Omeprazole and Adderall XR

Patients taking omeprazole can safely take Adderall XR as there is no clinically significant interaction between these medications. While PPIs like omeprazole can affect the metabolism of certain drugs through CYP enzyme inhibition, there is no evidence of a meaningful interaction with amphetamine-based medications like Adderall XR.

Pharmacological Considerations

Omeprazole

  • Omeprazole is a proton pump inhibitor (PPI) that reduces gastric acid production
  • It primarily inhibits CYP2C19 and has minimal effects on other CYP enzymes 1
  • PPIs are commonly prescribed for acid-related disorders and for gastroprotection in patients on certain medications

Adderall XR

  • Contains mixed amphetamine salts in a 3:1 ratio of d- and l-enantiomers 2
  • Provides extended-release formulation for once-daily dosing with 12-hour duration of action 3
  • Metabolized primarily through deamination, hydroxylation, and conjugation pathways, not primarily through CYP2C19

Evidence for Safety of Combination

The available evidence does not indicate any significant drug-drug interaction between omeprazole and amphetamine-based medications like Adderall XR:

  • Unlike the concerns with clopidogrel and omeprazole where PPI use may reduce the antiplatelet effects 4, there is no similar mechanism of concern for amphetamine metabolism
  • Omeprazole primarily inhibits CYP2C19, which is not a major pathway for amphetamine metabolism 1
  • The ADHD Management Guidelines do not list PPIs as medications that interact with stimulants 5

Clinical Recommendations

  1. Monitor for standard side effects of both medications:

    • For Adderall XR: cardiovascular effects (increased heart rate, blood pressure), insomnia, decreased appetite, weight loss 6
    • For omeprazole: headache, diarrhea, abdominal pain, nausea
  2. No dosage adjustments are needed when starting Adderall XR in a patient already taking omeprazole

  3. Follow standard ADHD medication monitoring:

    • Regular monitoring every 3-4 weeks during dose titration
    • Every 3-6 months once stabilized on an effective dose
    • Monitor vital signs, weight, sleep quality, and symptom control 5

Special Considerations

  • While there is no significant interaction between these medications, be aware that:
    • Omeprazole can increase gastric pH, which theoretically could affect drug absorption for some medications, but this has not been demonstrated to be clinically significant for amphetamine products
    • Adderall XR should be used with caution in patients with cardiovascular conditions, which should be monitored regardless of omeprazole use 6

Common Pitfalls to Avoid

  • Don't confuse with other drug interactions: Unlike the well-documented interaction between omeprazole and clopidogrel 4, there is no similar concern with Adderall XR
  • Don't unnecessarily discontinue omeprazole: If the patient requires both medications, there is no evidence-based reason to discontinue or adjust the omeprazole therapy
  • Don't overlook monitoring requirements: While there's no significant interaction, standard monitoring for both medications should still be maintained

In conclusion, based on the available evidence, patients can safely take Adderall XR while on omeprazole therapy without concerns about significant drug interactions or need for dosage adjustments.

References

Research

Adderall XR: long acting stimulant for single daily dosing.

Expert review of neurotherapeutics, 2004

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

ADHD Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Adderall® (amphetamine-dextroamphetamine) toxicity.

Topics in companion animal medicine, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.